Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000049

Options or other derivatives

  • EVP, Chief Business Officer acquired 41,825 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table II: Derivative

4 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2024-01-15 Grant or award : show line 1 in the form Performance Restricted Stock Units +17,000 $0.00 17,000 29,290 D
2024-01-15 Grant or award : show line 2 in the form Restricted Stock Unit +20,400 $0.00 20,400 67,661 D
2024-01-15 Grant or award : show line 3 in the form Restricted Stock Unit +1,800 $0.00 1,800 5,762 I
2024-01-15 Grant or award : show line 4 in the form Restricted Stock Unit +2,625 $0.00 2,625 8,387 I
Loading xslF345X05/edgardoc.xml…